Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol versus ibuprofen for patent ductus arteriosus treatment in preterm infants
2013-004955-19Phase 3Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in patent ductus arteriosus (PDA) and respiratory distress syndrome (RDS) comparing Paracetamol arm with Ibuprofen arm (2 arms). Primary endpoint: Rate of ductal closure after the first and second course of pharmacological treatment. Started May 2014; status: terminated.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2013-004955-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004955-19.